Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial ... MarketWatch (press release) ... sapacitabine in combination with cyclophosphamide and rituximab in patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and 11q22-23 deletion at The University of Texas MD Anderson Cancer Center. |
